Healthcare professionals (HCPs) expect digital experiences to be as seamless and personalised as the apps and services they ...

In a post on X.com, Neuralink said it had been granted regulatory approval for "a new feasibility trial to extend BCI control ...

The sell-off started last night and continued in after-hours trading after the New York-based biopharma company revealed that ...

The FDA is scrutinising reports of haematological cancers in patients treated with bluebird bio's gene therapy for the rare ...

Great Place to Work, Built Ins: Top Biotech Companies 2024, Forbes Best Places to Work in Life Sciences are joining our LEAP ...

The IL-5 inhibitor is already available under the Fasenra brand name for maintenance use in severe eosinophilic asthma, but a ...

Barcelona-based Grifols has seen its stock value plummet since January when short seller Gotham City Research accused the company of manipulating debt and earnings reporting by consolidating profit ...

Today, we live in an age of artificial intelligence (AI); more specifically, the age of generative AI (GenAI). In a recent report, 65% of respondents stated that their organisations are regularly ...

Jazz Pharmaceuticals has agreed another pipeline-building deal, this time paying $10 million upfront for rights to a KRAS inhibitor programme from UK biotech Redx Pharma, continuing a move into ...

Big data, artificial intelligence (AI), and machine learning (ML) are driving a technological revolution in healthcare. But with such rapid progress, understanding what these advancements mean in ...

Rebecca Douglas is a strategic leader with a passion for nurturing talent. With an award-winning track record in developing and managing training programmes at IPG Health Medical Communications ...